Document:

Exhibit 10.1

 

ASSEMBLY BIOSCIENCES, INC.

AMENDED AND RESTATED 2014 STOCK INCENTIVE
PLAN

RESTRICTED STOCK UNIT AWARD NOTICE

 

	 	 	 
	 	 	Grant Number
	 	 	 
	 	 	 
	 	 	 

 

You have
been granted Restricted Stock Units (“RSUs”) of Assembly Biosciences, Inc. (the “Company”),
as follows:

 

	Effective Date:	 	[   ], 201__
	 	 	 
	Vesting Commencement Date:	 	[   ], 201__
	 	 	 
	Total Number of RSUs Granted:	 	[   ]
	 	 	 
	Term/Expiration Date:	 	[   ]
	 	 	 
	Vesting Schedule:	 	[One-third to vest on the first anniversary of the Vesting Commencement Date; Remainder to vest in equal installments on the second and third anniversary of the Vesting Commencement Date.] [Specify Performance Metrics] [Specify Perfomance Metrics + Corporate Transaction and/or Separation of Service triggers]
	 	 	 
	Payment Date:	 	The Company shall deliver, to the Grantee named below, one Share (as defined in the Plan) in respect of each vested RSU.  Delivery shall be made as soon as practicable following the vesting date and in no event later than 30 days following the applicable vesting date.

 

By your signature and the signature
of the Company’s representative below, you and the Company agree that this RSU is granted under and governed by the terms
and conditions of the Assembly Biosciences, Inc. Amended and Restated 2014 Stock Incentive
Plan (the “Plan”) and the Restricted Stock Unit Agreement, all of
which are attached and made a part of this document.

 

	Dated:   	                	 	 	 
	 	 	 	 	 
	GRANTEE:	 	ASSEMBLY BIOSCIENCES, INC.
	 	 	 	 	 
	 	 	By:	                     
	[   ]	 	 	 	 
	 	 	 	Name:  	 
	 	 	 	 	 
	 	 	 	Title:	 

 

     

     

    

 

ASSEMBLY BIOSCIENCES, INC. 

RESTRICTED STOCK UNIT AWARD AGREEMENT

UNDER THE AMENDED AND RESTATED 2014 STOCK
INCENTIVE PLAN

 

THIS RESTRICTED
STOCK UNIT AWARD AGREEMENT (this “Award Agreement”) is made and entered into by and between Assembly Biosciences,
Inc. (the “Company”) and the individual named in the Restricted Stock Unit Award Notice (the “Grantee”)
under the Company’s Amended and Restated 2014 Stock Incentive Plan (the “Plan”). The Award Notice also
establishes the Effective Date of the Award, the number of Restricted Stock Units awarded, vesting conditions, and the Payment
Date of the Award.

 

WHEREAS, the Grantee is expected to provide
valuable services to the Company;

 

[Add additional recitals as desired];

 

WHEREAS, the Company considers it desirable
and in the best interests of the Company that the Grantee be given an opportunity to acquire a proprietary interest in the Company
as an incentive to advance the interests of the Company and to perform future services that will contribute materially to the successful
operation of the Company; and

 

WHEREAS,
the Company, acting through the Board of Directors of the Company (the “Board”) or (ii) the
Committee appointed by the Board under the Plan (the “Committee”), desires to
grant the Grantee a Restricted Stock Unit Award measured in shares of common stock of the Company (the “Common Stock”),
in accordance with the Plan. Capitalized terms used herein which are not otherwise defined herein shall have the meanings ascribed
to them under the Plan.

 

NOW, THEREFORE, in consideration of the
premises, it is agreed by and between the parties as follows:

 

1. Grant of Restricted Stock Unit Award. The Company awards the Grantee Restricted Stock Units in a number that
is specified in the Award Notice provided to the Grantee. The Award is subject to the vesting, payment and other provisions of
this Award Agreement, the Award Notice and the Plan. Each Restricted Stock Unit represents one (1) Share of Common Stock of the
Company. The Company will account for the Restricted Stock Units in a bookkeeping account on the Grantee’s behalf until they
become payable or are forfeited. The number of Restricted Stock Units shall be adjusted if the Common Stock is split, combined,
if stock dividends are paid on Common Stock, or upon a similar event in the same manner
that the Common Stock is adjusted.

 

2. Dividend Equivalents. For each Restricted Stock Unit that is granted and credited to the Grantee’s account,
the Grantee’s account will also be credited with a Dividend Equivalent Rights in an amount equal to any cash dividends paid
by the Company upon one Share of Common Stock after the Effective Date and before the Payment Date (as provided in the Award Notice)
for the Restricted Stock Unit, subject to the vesting and other provisions of this Award Agreement and the Award Notice.

 

     

     

    

 

3. Vesting. The Restricted Stock Units (and Dividend Equivalent Rights associated with the Restricted Stock Units) shall
be unvested and shall be subject to the restrictions set forth in this Award Agreement and the Award Notice. Unless sooner forfeited
in accordance with Section 5, the Restricted Stock Units and Dividend Equivalent Rights associated with the Restricted Stock Unit
shall be vested for a Grantee as set forth in the Grantee’s Award Notice.

 

4. Settlement of Vested Restricted Stock Units and Restricted Dividend Equivalents.If any of the Restricted Stock
Units vest on a Vesting Date, the Company shall settle such Restricted Stock Units (the “Vested Restricted Stock Units”)
and Dividend Equivalent Rights attributable to such Vested Restricted Stock Units (“Vested Dividend Equivalents”)
on the Payment Date established in the Award Notice (the “Payment Date”) by delivering to the Grantee (a) a
certificate for shares of Common Stock of the Company and (b) cash, determined as follows:

 

		(a)	Number of Shares of Common Stock. The Company will determine the value as of the Payment Date of the Vested Restricted
Stock Units and the Vested Dividend Equivalent Rights (together, the “Total Amount”). For this purpose, the
Vested Dividend Equivalents shall be valued at their original value and shall not be increased or decreased by an interest or earnings
factor. The Total Amount will be reduced by any tax withholding that is not paid by the Grantee under the procedure in Section
6 below (the amount after the reduction is the “Net Amount”). The Net Amount will be divided by the value of
one (1) Common Share of the Company as of the Vesting Date, and the resulting whole number (without remainder) shall be the number
of shares of Common Stock that will be delivered to the Grantee, and

 

		(b)	Cash. The remainder resulting from the division in (a) above to determine the number of shares of Common Stock will
be the dollar amount of the cash payable to the Grantee, and such amount shall be paid to the Grantee by check.

 

The Vested Restricted Stock Units and Vested
Dividend Equivalents will be settled by the Company within thirty (30) days of the Payment Date.

 

5. Forfeiture of Restricted Stock Units (and Dividend Equivalent Rights Attributable to Restricted Stock Units). In
the event of Termination of Employment of the Grantee from the Company for any reason (including Disability), any Restricted Stock
Units and Dividend Equivalent Rights attributable to such Restricted Stock Units that were not already vested on the termination
of Employment shall be forfeited on that date.

 

6. Certain Tax Matters. The Grantee acknowledges that the Grantee understands the federal, state and local income, employment
and foreign (if applicable) tax consequences of the Restricted Stock Unit Award, and the issuance, vesting and forfeiture provisions
relating to the Restricted Stock Unit Award.

 

     

     

    

 

The Grantee understands that, at the time
that the Grantee realizes any compensation income in respect of the Restricted Stock Unit Award, the Company will be required to
withhold federal, state and local income and employment taxes on the full amount of the compensation income realized by the Grantee,
and if the Grantee is located outside of the United States, the Company may be required to withhold to meet tax, employment, or
other obligations imposed by the tax jurisdiction that may be applicable to the Grantee. It is understood that all matters with
respect to the total amount of taxes to be withheld in respect of such compensation income shall be determined by the Board (or
the Committee) in its reasonable discretion. It is understood that although the Company may pay withheld amounts for the taxing
jurisdiction that may be credited to the Grantee against taxes due by the Grantee, the Grantee is responsible for payment of all
taxes due as a result of compensation arising under this Award Agreement.

 

The Board (or the Committee) may make such
provisions and take such steps as it may deem necessary or appropriate for the withholding of taxes by the Company on compensation
income the Grantee realizes. The Company shall accept payment by the Grantee of an amount in cash for all or part of the
withholding obligation of the Company on the compensation income, so that the payment(s) to the Grantee under this Award Agreement
are not reduced for tax withholding to the extent of the payment. Such payment by the Grantee must be made to the Company by the
time that the Company is required to pay the withholding to the taxing authority, but in any event not later than thirty (30) days
from the Payment Date. If the Grantee does not make a payment for the full withholding obligation, the Company shall withhold part
of the payment due for redemption of the Vested Restricted Stock Units and Vested Dividend Equivalent Rights in the amount needed
by the Company to meet its withholding obligations, with the result that the payment amount for the Vested Restricted Stock Units
and Vested Dividend Equivalent Rights will be reduced as provided in Section 4(a) above by the amount needed to meet the Company’s
withholding obligations.

 

7. Rights Prior to Vesting. The Restricted Stock Units and Dividend Equivalent Rights represent a right to payment from
the Company if the conditions of this Award Agreement are met and do not give the Grantee ownership of any Common Stock prior to
delivery as provided in Section 4. No assets have been set aside by the Company or otherwise to pay the amounts promised by this
Award Agreement, the right to payment is unsecured, and the Grantee is a general creditor of the Company for payment under this
Award Agreement.

 

8. Investment Representation. The Grantee represents and warrants to the Company that the Grantee has read this Award
Agreement carefully, and to the extent believed necessary, has discussed this Award Agreement and its impact and limitations upon
the Grantee with counsel.

 

9. Transferability. The right to payment under this Award Agreement may not be sold, exchanged, transferred, pledged,
hypothecated, encumbered or otherwise disposed of except as provided in the Plan. The Company shall have the right to assign to
any of its affiliates any of its rights, or to delegate to any of its affiliates any of its obligations under this Award Agreement.

 

     

     

    

 

10. Binding Effect. This Award Agreement shall inure to the benefit of and be binding upon the parties hereto and their
respective heirs, executors, administrators, successors and assigns.

 

11. Gender and Number. All terms used in this Award Agreement shall be deemed to refer to the masculine, feminine, neuter,
singular or plural as the context may require.

 

12. Terms and Conditions of Plan. The terms and conditions included in the Plan and the Award Notice are incorporated
by reference herein, and to the extent that any conflict may exist between any term or provision of this Award Agreement and any
term or provision of the Plan as in effect from time to time, such term or provision of the Plan shall control.

 

13. Certain Remedies. Without intending to limit the remedies available to the Company, the Grantee agrees that damages
at law will be an insufficient remedy in the event the Grantee violates the terms of this Award Agreement. The Grantee agrees that
the Company may apply for and have injunctive or other equitable relief in any court of competent jurisdiction to restrain the
breach or threatened breach of, or otherwise specifically to enforce, any of the provisions hereof.

 

14. Waiver. The waiver by either party of compliance with any provision of this Award Agreement by the other party shall
not operate or be construed as a waiver of any other provision of this Award Agreement, or of any subsequent breach by such party
of a provision of this Award Agreement.

 

15. No Restriction on Right of Company to Effect Corporate Changes. Neither the Plan nor this Award Agreement shall
affect in any way the right or power of the Company or its stockholders to make or authorize any or all adjustments, recapitalizations,
reorganizations or other changes in the capital structure or business of the Company, or any merger or consolidation of the Company,
or any issue of stock or of options, warrants or rights to purchase stock or of bonds, debentures, preferred or prior preference
stocks whose rights are superior to or affect the Common Stock or the rights thereof or which are convertible into or exchangeable
for Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of the assets or
business of the Company, or any other corporate act or proceeding, whether of a similar character or otherwise.

 

16. Entire
Agreement. This Award Agreement (including the Award Notice, and the Plan which is incorporated herein by reference and all
additional riders incorporated herein) sets forth all of the promises, agreements, conditions and understandings between the parties
hereto with respect to the Award, and there are no promises, agreements, conditions, understandings, warranties or representations,
oral or written, express or implied, between them with respect to the Restricted Stock Unit Award other than as set forth therein
or herein. This Award Agreement supersedes and replaces any and all prior agreements between the parties hereto with respect to
Restricted Stock Units and Dividend Equivalent Rights. This Award Agreement is, and is intended by the parties to be, an integration
of any and all prior agreements or understandings, oral or written, with respect to Restricted Stock Units and Dividend Equivalent
Rights. No modification, amendment or waiver of any of the provisions of this Award Agreement shall be effective unless approved
in writing by both parties.

 

     

     

    

 

17. Invalid
or Unenforceable Provision. The invalidity or unenforceability of any particular provision of this Award Agreement shall not
affect the other provisions hereof, and this Award Agreement shall be construed in all respects as if such invalid or unenforceable
provision was omitted.

 

18. Governing
Law. This Award Agreement shall be construed and enforced in accordance with the laws of Delaware, without giving effect to
principles of conflicts of laws.

 

19. Miscellaneous.

 

(a) Neither the granting or vesting of the Restricted Stock Units and Dividend Equivalent Rights nor
any other provision of this Award Agreement shall be construed as conferring upon the Grantee any right to continue in the employment
of the Company, or as interfering with or restricting in any way the right of the Company to terminate such employment at any time.

 

(b) The Company, the Board (or the Committee) and any employees or agents thereof are relieved from any liability for the non-issuance
or non-transfer, or any delay in the issuance or transfer, of any Common Stock which results from the inability of the Company
to obtain, or in any delay in obtaining, from each regulatory body having jurisdiction all requisite authority to issue or transfer
the Common Stock in satisfaction of this Award Agreement if counsel for the Company deems such authorization necessary for the
lawful issuance or transfer of any of the Common Stock.

 

(c) No Common Stock shall be sold or otherwise disposed of in violation of any federal or state securities law or regulations.

 

(d) All decisions of the Board (or the Committee) with respect to the interpretation, construction and application of the Plan
and/or this Award Agreement shall be conclusive and binding upon the Grantee and all other persons.

 

(e) This Award Agreement has been drafted with the intent that payments (and the right to payments) under it comply with
the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations thereunder applicable to
nonqualified deferred compensation. This Award Agreement shall be interpreted in a manner consistent with such intent.trtc_ex415.htm

EXHIBIT 4.15
  
 NEITHER THIS NOTE NOR THE SECURITIES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND HAS BEEN TAKEN FOR INVESTMENT PURPOSES ONLY AND NOT WITH A VIEW TO OR FOR SALE IN CONNECTION WITH ANY DISTRIBUTION THEREOF. IT MAY NOT BE SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION AND QUALIFICATIONS WITHOUT, EXCEPT UNDER CERTAIN SPECIFIC LIMITED CIRCUMSTANCES, AN OPINION OF COUNSEL FOR PAYEE, CONCURRED IN BY COUNSEL FOR OBLIGOR THAT SUCH REGISTRATION AND QUALIFICATION ARE NOT REQUIRED.
  
 NULEAF SPARKS CULTIVATION, LLC
  
 CONVERTIBLE PROMISSORY NOTE
  
  	 $3,619,134.02
	 October 30, 2017

  
 NuLeaf Sparks Cultivation, LLC, a Nevada limited liability company, and NuLeaf, Inc., a Nevada corporation (collectively, “Obligor”), for value received, hereby promises to pay to the order of MediFarm III, LLC, a Nevada limited liability company (“Payee”), the aggregate principal amount outstanding of Three Million Six Hundred Nineteen Thousand One Hundred Thirty Four Dollars and 02/100 ($3,619,134.02) under this Promissory Note (hereinafter sometimes referred to as this “Note”) upon maturity as set forth below together with interest as set forth herein. Interest on this Note shall be computed on the basis of a year of 365 days for the actual number of days elapsed. 
  
 1. Convertible Loan Agreement. This Note is being issued in conjunction with that certain Convertible Loan Agreement of even date herewith (the “Loan Agreement”) where the capitalized terms used herein shall have the meanings prescribed for in the Loan Agreement. The debts, liabilities and obligations of Obligor to Payee under this Note, including all unpaid principal and all interest accrued hereon, whether due or to become due, absolute or contingent, liquidated or unliquidated, determined or undetermined shall be referred to as the “Obligations”. All payments shall be applied first to accrued interest, and thereafter to principal. 
  
 2. Interest Rate. The outstanding principal amount shall bear interest from the date of this Note at a rate of six percent (6%) per annum, where said interest shall accrue and be paid on a quarterly basis; provided, however, in the event that the Obligor has obtained, or entered into an agreement to obtain, additional capital and/or financing during the Financing Period (as defined in the Loan Agreement) bearing a minimum rate of return, preferred return or interest rate in excess of the then stated interest rate of this Note, this Note shall immediately bear interest at the higher rate, where said increase shall be effective upon the date on which the higher rate starts to accrue. Interest shall be computed on the basis of the actual number of days elapsed and a year of three hundred sixty (360) days.
  
 3. Default Rate. Upon the occurrence of an Event of Default (as defined herein) under this Note or the Loan Agreement, interest shall accrue on all outstanding principal at a rate equal to the Interest Rate plus six percent (6%) per annum (the “Default Rate”). 
  
 4. Prepayment. This Note may not be prepaid by the Company without the prior written consent of the Payee.
  
 5. Priority. This Note shall rank senior to any and all other loans, advances, debts, liabilities, obligations, covenants and duties of Obligor.
   	 
	PAGE 1 OF 4
	 
 
	 

  
 6. Conversion. In accordance with Section 2 of the Loan Agreement, the principal amount of this Note shall be automatically convertible into fifty percent (50%) of the outstanding Membership Interest of NuLeaf Sparks Cultivation, LLC upon the receipt of the approvals for the admission of Payee as a member of NuLeaf Sparks Cultivation, LLC from the Regulatory Authorities (as defined in the Loan Agreement). 
  
 7. Maturity Date. In the event Payee does not receive all permits, licenses and approvals which are required to be obtained from Regulatory Authorities in order to own and operate the MME Cultivation Facility by May 1, 2018, this Note shall become due and payable in equal quarterly payments of principal and interest due thereon in lawful money of the United States of America, with the first such payment being due on August 1, 2018.
  
 8. Cancellation of Note. Upon payment in full of all principal and interest payable hereunder, or upon conversion of this Note into Membership Interests of NuLeaf Sparks Cultivation, LLC, this Note shall be surrendered to Obligor for cancellation. 
  
 9. Events of Default. Any of the following events which shall occur shall constitute an “Event of Default”:
  
 a. Obligor shall fail to pay when due any amount of principal or interest hereunder or other amount payable hereunder, where such failure continues for five (5) days after receipt of written notice from Payee specifying such failure; or
  
 b. Any representation or warranty made or furnished by or on behalf of Obligor to Payee in writing in connection with this Note or the Loan Agreement shall be false, incorrect, incomplete or misleading in any material respect when made or furnished.
  
 Upon the occurrence of any Event of Default, the outstanding principal balance and accrued interest hereunder together with any additional amounts payable hereunder shall be immediately due and payable without demand or notice of any kind, this Note will bear interest at the Default Rate from the date of the occurrence of the Event of Default, and Payee may exercise from time to time any of the rights and remedies available under the Loan Agreement or under applicable law.
  
 10. Time is of the Essence. Time is of the essence in the performance of this Note.
  
 11. Waivers. Obligor waives presentment, demand for performance, notice of nonperformance, protest, notice of protest, and notice of dishonor. No delay on the part of Payee in exercising any right hereunder shall operate as a waiver of such right under this Note. 
  
 12. Fees and Costs. If the Indebtedness presented by this Note or any part thereof is collected at law or in equity or in bankruptcy, receivership or other judicial proceedings or if this Note is placed in the hands of attorneys for collection after default, Obligor agrees to pay, in addition to the principal and interest payable thereon, reasonable attorneys’ fees and costs incurred by Payee.
  
 13. Amendments and Waivers. No amendment or waiver of any provision of the Note, nor consent to any departure by Obligor therefrom, shall be effective unless the same shall be in writing and signed by the Payee and the Obligor, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given. Any amendment or waiver effected in accordance with this paragraph shall be binding upon Obligor, Payee and each transferee of this Note.
   	 
	PAGE 2 OF 4
	 
 
	 

  
 14. Notice. Any notice or other communication (except payment) required or permitted hereunder shall be in writing and shall be deemed to have been given upon delivery if personally delivered or three business days following deposit if deposited in the United States mail for mailing by certified mail, postage prepaid, and addressed as follows:
  
  	  
	 If to Payee:
	 MediFarm III, LLC 
 c/o Terra Tech Corp. 
 2040 Main Street, Suite 225
 Irvine, CA 92614
 Attn: CEO

	  
	  
	  

	  
	 If to Obligor:
	 NuLeaf Sparks Cultivation, LLC
 c/o Puoy K. Premsrirut, Esq.
 520 South Fourth Street
 Second Floor
 Las Vegas, NV 89101

  
 Any payment shall be deemed made upon receipt by Payee. Each of the above addressees may change its address for purposes of this paragraph by giving to the other addressee notice of such new address in conformance with this paragraph.
  
 15. Usury. Notwithstanding anything herein to the contrary, payment of any interest, expense or other amount shall not be required if such payment would be unlawful. In any such event, the note shall automatically be deemed amended so that interest charges and all other payments required hereunder, individually and in the aggregate, shall be equal to but not greater than the maximum permitted by law.
  
 16. Further Assurances. Each party shall execute, acknowledge, deliver, file, notarize and register (at its own expense) all documents, instruments, certificates, agreements and assurances and provide all information and take or forbear from all such action as the other party may reasonably deem necessary or appropriate to achieve the purposes of this Note or satisfy the Obligations hereunder.
  
 17. Severability. Whenever possible, each provision of this Note shall be interpreted in such manner as to be effective and valid under all applicable laws and regulations. If, however, any provision of this Note shall be prohibited by or be invalid under any such law or regulation in any jurisdiction, it shall, as to such jurisdiction, be deemed modified to conform to the minimum requirements of such law or regulation, or, if for any reason it is not deemed so modified, it shall be ineffective and invalid only to the extent of such prohibition or invalidity without affecting the remaining provisions of this Note, or the validity or effectiveness of such provision in any other jurisdiction.
  
 18. Construction. This Note is the result of negotiations among, and has been reviewed by, the Obligor, the Payee and their respective counsel. Accordingly, this Note shall be deemed to be the product of all parties hereto, and no ambiguity shall be construed in favor of or against the Obligor or the Payee.
  
 19. Governing Law and Jurisdiction. This Note and all actions arising out of or in connection with this Note shall be governed by and construed in accordance with the internal laws of the State of Nevada, without regard to the conflicts of law rules of the State of Nevada or of any other jurisdiction.
  
 [SIGNATURE PAGE FOLLOWS]
   	 
	PAGE 3 OF 4
	 
 
	 

  
 IN WITNESS WHEREOF, Obligor and Payee have executed this Convertible Promissory Note as of the date first written above.
  
  
 OBLIGOR:
  
 NULEAF SPARKS CULTIVATION, LLC, 
 a Nevada limited liability company
  
  	 By:
	  
	  

	  
	  
	  

	 Title:
	 Manager
	  

  
 PAYEE:
  
 MEDIFARM III, LLC,
 a Nevada limited liability company
  
  	 By:
	 Terra Tech Corp.
	  

	 Title:
	 Authorized Member
	  

  
  	  
	 By:
	  
	  

	  
	  
	  
	  

	  
	 Title:
	 Manager
	  

  
  
  	 PAGE 4 OF 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}]]